Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study

ConclusionsThese data provide evidence that NH reduces office BP more than IH but has similar effects on 24-h BP. NH reduces 24-h systolic and diastolic BP variability more than IH, suggesting a greater protective effect on a variable known to adversely affect prognosis.Trial RegistrationEU clinical Trials Register identifier, 2010-023104-28.FundingMenarini International Operations Luxembourg.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research